Close

RBC Capital Upgrades Karyopharm Therapeutics (KPTI) to Outperform Nov 4, 2022 05:15AM
Karyopharm to Participate at the 2022 RBC Capital Markets Global Healthcare Conference May 10, 2022 07:00AM
Karyopharm Therapeutics (KPTI) Wild Ride Occurring as M&A Speculation Proved Wrong Amid Executive Departure - RBC Feb 22, 2022 12:40PM
UPDATE: RBC Capital Downgrades Karyopharm Therapeutics (KPTI) to Sector Perform Aug 5, 2021 04:05PM
Karyopharm Therapeutics (KPTI) Current Valuation Underestimates Xpovio Benefit - RBC Capital Mar 29, 2021 06:29AM


Jun 8, 2020 07:31AM Karyopharm Therapeutics (KPTI) Opportunity Seems Underappreciated Post Physician Checks - RBC Capital
May 12, 2020 07:00AM Karyopharm to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference
Mar 6, 2020 04:05PM Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Mar 4, 2020 05:54AM Karyopharm Therapeutics (KPTI) Prices 6.25M Share Common Offering at $24/Sh
Mar 3, 2020 06:36PM Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
Mar 2, 2020 01:12PM Karyopharm Therapeutics (KPTI) PT Raised to $37 at RBC Capital
Jul 5, 2019 05:29AM Karyopharm Therapeutics (KPTI) PT Raised to $22 at RBC Capital
May 8, 2019 07:00AM Karyopharm to Participate in Upcoming Investor Conferences
May 8, 2019 07:00AM Karyopharm to Participate in Upcoming Investor Conferences
Mar 15, 2019 09:05AM Karyopharm Therapeutics (KPTI) PDUFA Delay Signals FDA Receptivity - RBC
Mar 1, 2019 06:49AM Karyopharm Therapeutics (KPTI) PT Lowered to $16 at RBC Capital
Feb 27, 2019 06:29AM RBC Still Sees Value for Karyopharm Therapeutics' (KPTI) Selinexor Albeit Delayed, PT To $17
Jan 3, 2019 03:59PM Bristol-Myers/Celgene Deal Likely Kicks Off 'Big Year' In Biopharma M&A - RBC
Dec 3, 2018 09:25AM Pre-Open Movers 12/03: (TSRO) (GBT) (NBEV) Higher; (OCUL) (BLUE) (GSK) Lower (more...)
Nov 26, 2018 06:51AM Buy Karyopharm (KPTI) Into ASH - RBC
Oct 8, 2018 10:58AM RBC Capital Remains Buyers of Karyopharm Therapeutics (KPTI) Following 8% Gain
Aug 7, 2018 02:32PM Karyopharm Therapeutics (KPTI) PT Lowered to $25 at RBC Capital, Remains Positive
May 1, 2018 07:58AM Karyopharm Therapeutics (KPTI) PT Raised to $24 at RBC Capital; 'We Would Be Buyers'
Feb 7, 2018 07:00AM Karyopharm to Participate in Upcoming Investor Conferences
Feb 7, 2018 07:00AM Karyopharm to Participate in Upcoming Investor Conferences
Sep 14, 2017 04:28PM RBC Capital Starts Karyopharm Therapeutics (KPTI) at Outperform
Aug 18, 2016 10:44AM Notable Analyst Rating Changes 8/18: (PCLN) (KMI) (TOO) Upgraded; (TWTR) (HMSY) (MMP) Downgraded
Jun 28, 2016 10:48AM Notable Analyst Rating Changes 6/28: (TRV) (OLN) (RIO) Upgraded; (DISH) (LB) (DD) Downgraded
Jun 26, 2014 09:25AM Pre-Open Stock Movers 6/26: (QLTI) (UNXL) (IRM) Higher; (RDEN) (BBBY) (MLHR) Lower (more...)
Feb 6, 2014 08:30AM Karyopharm Therapeutics to Present at Upcoming Healthcare Conferences in February